9 May, 2007
Parkinson’s patch approved
Federal Food & Drug AdministrationParkinson's diseaseAnnouncement0 Comments
0
0
Lynn B. Schramek
Lynn B. Schramek2015-05-12 10:22:242015-05-12 12:12:46Parkinson’s patch approvedThe FDA approves Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver a drug called rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.
FDA approval
Federal Food & Drug AdministrationParkinson's diseaseAnnouncement0 Comments
0
0
Lynn B. Schramek
Lynn B. Schramek2015-06-15 10:52:132015-06-15 15:01:38FDA approval
The FDA announces the approval of Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.